561 related articles for article (PubMed ID: 16125538)
1. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
2. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
3. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
5. Effect of JTT-501 on net hepatic glucose balance and peripheral glucose uptake in alloxan-induced diabetic dogs.
Niwa M; Rashid S; Shum K; Mathoo JM; Chan O; Tchipashvili V; Kawamori R; Vranic M; Giacca A
Metabolism; 2000 Jul; 49(7):862-7. PubMed ID: 10909996
[TBL] [Abstract][Full Text] [Related]
6. Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia.
Gupta N; Sandhu H; Goh T; Shah K; Wiesenthal SR; Yoshii H; Chong V; Lam TK; Haber CA; Williams W; Tchipashvili V; Giacca A
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1002-7. PubMed ID: 12376328
[TBL] [Abstract][Full Text] [Related]
7. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
8. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
Li L; Yang GY
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
[TBL] [Abstract][Full Text] [Related]
9. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
Tuman RW; Bowden CR; Inman M; Altszuler N; Tutwiler GF
J Pharmacol Exp Ther; 1989 Sep; 250(3):836-41. PubMed ID: 2674419
[TBL] [Abstract][Full Text] [Related]
10. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
11. The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs.
Matsuhisa M; Shi ZQ; Wan C; Lekas M; Rodgers CD; Giacca A; Kawamori R; Vranic M
Diabetes; 1997 Feb; 46(2):224-31. PubMed ID: 9000698
[TBL] [Abstract][Full Text] [Related]
12. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
[TBL] [Abstract][Full Text] [Related]
14. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Keller U; Müller R; Berger W
Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
[TBL] [Abstract][Full Text] [Related]
15. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
16. Effect of hyperglycemia on hepatic extraction of insulin in totally pancreatectomized dogs.
Doi K; Morita S; Nakata K; Baba S
Kobe J Med Sci; 1989 Apr; 35(2):121-30. PubMed ID: 2677518
[TBL] [Abstract][Full Text] [Related]
17. Prior exercise and the response to insulin-induced hypoglycemia in the dog.
Koyama Y; Galassetti P; Coker RH; Pencek RR; Lacy DB; Davis SN; Wasserman DH
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1128-38. PubMed ID: 11934679
[TBL] [Abstract][Full Text] [Related]
18. Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
Moore MC; Dicostanzo CA; Smith MS; Farmer B; Rodewald TD; Neal DW; Williams PE; Cherrington AD
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E768-77. PubMed ID: 18212022
[TBL] [Abstract][Full Text] [Related]
19. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux.
Yoshii H; Lam TK; Gupta N; Goh T; Haber CA; Uchino H; Kim TT; Chong VZ; Shah K; Fantus IG; Mari A; Kawamori R; Giacca A
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1089-97. PubMed ID: 16390863
[TBL] [Abstract][Full Text] [Related]
20. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
